FAPI PET Not Yet Validated for Thyroid Cancer Response
A narrative review indicates that FAPI PET is not yet a validated biomarker for assessing treatment response in radioiodine-refractory differentiated ...
A narrative review indicates that FAPI PET is not yet a validated biomarker for assessing treatment response in radioiodine-refractory differentiated ...
A comparative analysis of the phase III ASCENT-03 and TROPION-Breast02 trials demonstrates that first-line TROP2-targeting antibody–drug conjugates consistently improve progression-free ...
A meta-analysis of 13 randomized trials found that adding immune checkpoint inhibitors does not significantly improve survival outcomes in unselected ...
A retrospective cohort study found that local tumor response following hypofractionated radiotherapy combined with systemic therapy was independently associated with ...
A retrospective study of 60 Chinese patients with metastatic renal cell carcinoma receiving first-line ipilimumab plus nivolumab showed progression-free survival ...
A causal inference analysis of 2,610 lymphoma patients reveals that shorter diagnosis-to-treatment intervals improve overall survival after adjusting for baseline ...
A deep learning model combining pretreatment CT imaging and clinical markers accurately predicts objective tumor response and survival outcomes in ...
A prospective phase II trial protocol outlines plans to evaluate standard first-line immunotherapy regimens in metastatic non-small cell lung cancer ...
In a retrospective cohort of 283 women with triple-negative breast cancer, FOXA1 expression served as an independent biomarker of poor ...
A long-term clinical investigation reveals that glioma infiltration into the corticospinal tract significantly elevates postoperative paralysis risks despite surgical electrical ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine